Minetta C. Liu, M.D.

  1. Oncologist
  • Breast cancer
  • Prognostic/predictive biomarkers
  • Circulating tumor cell isolation and characterization
  • Cell free DNA isolation and analysis
  • Clinical trials
  • Novel therapeutics
  • Molecular diagnostics
  • Early Cancer Therapeutics/Phase 1 Clinical Trials
  1. 2001
    FellowDivision of Hematology/Oncology, Georgetown University Medical Center
  2. 1998
    ResidentDepartment of Medicine, Georgetown University Medical Center
  3. 1995
    MDJefferson Medical College
  4. 1991
    AB - AB in Molecular BiologyPrinceton University

Certifications

  1. 2001
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2017
    Best Doctors in AmericaBest Doctors Inc.
  2. 2017
    Albert Nelson Marquis Lifetime Achievement AwardMarquis Who's Who
  3. 2012
    Sarah Stewart LectureshipGeorgetown University
  4. 2009
    Honored Member, Who's Who in Medicine and HealthcareMarquis Who's Who
  5. 2007
    Certificate of Excellence in Teaching Medical StudentsDepartment of Medicine, Georgetown University Medical Center
  6. 2004
    America's Top PhysiciansConsumers Research Council of America
  7. 2001
    Honored Member, America's Registry of Outstanding ProfessionalsConsumers Research Council of America
  8. 2000
    Selected Workshop Participant, "Methods in Clinical Cancer Research"American Association for Cancer Research
  9. 1998
    Award for Excellence in Providing Comprehensive Outpatient CareDepartment of Medicine, Georgetown University Medical Center
  10. 1994
    Hobart Amory Hare Medical Honor SocietyJefferson Medical College
  11. 1992
    Scholarship Recipient, Cancer Research ProgramJefferson Medical College
  12. 1991
    Junior and Senior Thesis with HonorsPrinceton University
  13. 1991
    AB in Molecular Biology, Cum LaudePrinceton University

Professional memberships

  1. 2018 - present
    Physician LeaderMidwest Financial Planning Group
  2. 2018 - present
    MemberMayo Clinic Clinical Practice Committee; Midwest Clinical Practice Committee
  3. 2018 - present
    MemberMayo Clinic Cancer Center Communications Committee
  4. 2018 - present
    Data Monitoring Safety BoardNSABP B59/GBG 96-GeparDouze
  5. 2018 - present
    MemberPALLAS Translational Research Committee
  6. 2018 - present
    MemberTrans-ALTTO Research Committee
  7. 2017 - present
    MemberSpecialty Contract Operations Oversight Group, Outpatient Care Delivery Platform; Specialty Contract Operations Oversight Group
  8. 2017 - present
    ReviewerCancer and Leukemia Group B / Alliance for Clinical Trials in Oncology, Publications Committee
  9. 2017 - present
    MemberISPY-2 Clinical Trials Program, Safety Working Group
  10. 2017 - present
    MemberISPY-2 Clinical Trials Program, Biomarker Working Group
  11. 2017 - present
    MemberSan Antonio Breast Cancer Symposium, Abstract Review Committee
  12. 2016 - present
    Associate Medical DirectorDepartment of Development
  13. 2016 - present
    Medical DirectorOutpatient Care Delivery Platform; Specialty Contract Operations Oversight Group
  14. 2016 - present
    MemberMayo Clinic Rochester Workgroups; Tumor Immunology Working Group
  15. 2016 - present
    Board of Trustees MemberAlliance for Clinical Trials in Oncology Board of Trustees
  16. 2016 - present
    MemberFoundation for the National Institutes of Health, Biomarkers Consortium Cancer Steering Committee, Subgroup on Clinical Utility of Liquid Biopsies
  17. 2016 - present
    LeaderMetastatic Breast Cancer Alliance, Accelerator Project, Clinical Trials Initiative
  18. 2016 - present
    Co-ChairTranslational Breast Cancer Research Consortium, Correlative Science Committee
  19. 2015 - present
    Academic and Community Cancer Research United, Mayo Clinic Cancer Center
  20. 2015 - present
    ChairResearch Committee, Division of Medical Oncology, Department of Oncology
  21. 2015 - present
    Group LeaderDepartment of Oncology; Division of Medical Oncology; Physicians' Engagement Group
  22. 2015 - present
    MemberTranslational Research Program Executive Committee, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  23. 2015 - present
    Co-ChairClinical Working Group, AURORA US, Evelyn H. Lauder Founder's Fund Collaboration
  24. 2015 - present
    Alternate MemberCorrelative Sciences Committee, NCI National Clinical Trials Network
  25. 2015 - present
    RepresentativeBoard of Directors, Academic and Community Cancer Research United
  26. 2014 - present
    Physician LeadCare Coordination, Mayo Clinic Specialty Cancer Care Advisory Group
  27. 2014 - present
    MemberBreast SPORE; Operations Committee
  28. 2014 - present
    Co-ChairDepartment of Laboratory Medicine and Pathology; DLMP Molecular Diagnostic Breast Cancer Disease Oriented Group
  29. 2014 - present
    MemberHematology/Oncology Fellowship Selection Committee, Department of Oncology
  30. 2014 - present
    MemberBreast Committee, Alliance for Clinical Trials in Oncology
  31. 2014 - present
    MemberAlliance for Clinical Trials in Oncology Translational Research Program Executive Committee
  32. 2013 - 2014
    MemberDLMP Molecular Diagnostic Breast Disease Oriented Group, Department of Laboratory Medicine and Pathology
  33. 2013 - present
    Chair and FounderCirculating Tumor Cell and cfDNA Working Group, Mayo Clinic Rochester Workgroups
  34. 2013 - present
    MemberInpatient Clinical Practice Committee, Division of Medical Oncology, Department of Oncology
  35. 2013 - present
    MemberBreast Cancer Specialty Council, Mayo Clinic Specialty Council, Mayo Clinic Clinical Practice Committee
  36. 2013 - present
    MemberWorking Group on High Content Data Integration, Biomarkers Consortium Cancer Steering Committee, Foundation for the National Institutes of Health
  37. 2013 - present
    MemberAmerican Medical Women's Association
  38. 2012
    MemberEquipment, Space, and Capital Projects Committee, Georgetown University
  39. 2012 - present
    MemberOncology Breast Cancer Disease Oriented Group, Department of Oncology
  40. 2012 - present
    MemberOncology Phase I Disease Oriented Group, Department of Oncology
  41. 2012 - present
    Committee Member /AuthorBreast Cancer Biomarker Consensus Panel (Adjuvant), American Society of Clinical Oncology
  42. 2011 - 2012
    Academic and Community Cancer Research United, Mayo Clinic Cancer Center
  43. 2011 - 2012
    MemberBiostatistics Department Chair Search Committee, Georgetown University
  44. 2011 - 2012
    AdvisorBreast Cancer Patient Advocacy Committee, Georgetown University
  45. 2011 - 2012
    RepresentativeBoard of Directors, Academic and Community Cancer Research United
  46. 2011
    Co-FounderBreast Cancer Patient Advocacy Committee, Georgetown University
  47. 2011 - present
    MemberWorking Group on Circulating Tumor Cells, Biomarkers Consortium Cancer Steering Committee, Foundation for the National Institutes of Health
  48. 2011 - present
    MemberISPY-2 Clinical Trials Program, Agents Selection Committee
  49. 2010 - 2012
    MemberSponsored Research Working Group, Georgetown University
  50. 2009 - 2012
    MemberResearch Committee, Georgetown University
  51. 2008 - 2012
    MemberClinical Faculty Task Force, Georgetown University Medical Center
  52. 2008 - 2011
    MemberExecutive Committee, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  53. 2008 - 2010
    MemberDivision of Hematology/Oncology Merit Review Committee, Georgetown University Medical Center
  54. 2008 - 2010
    MemberConsensus Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, Institute of Medicine
  55. 2008 - 2009
    MemberMission and Vision Working Group, Georgetown University
  56. 2008 - 2009
    MemberCollaboration, Partnerships, and Communications Design Team, Georgetown University
  57. 2007 - 2012
    MemberBoard of Directors, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  58. 2007 - present
    Advisory Board MemberSyrentha Savio Endowment
  59. 2007 - present
    MemberBoard of Trustees, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  60. 2006 - 2012
    ChairData and Safety Monitoring Committee, Georgetown University
  61. 2006 - 2009
    MemberCancer Education Committee, American Society of Clinical Oncology
  62. 2005 - present
    Cadre MemberData Audit Committee, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  63. 2005 - present
    Principal InvestigatorThe Translational Breast Cancer Research Consortium
  64. 2004 - present
    Cadre MemberBreast Committee, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  65. 2003 - 2006
    MemberInstitutional Review Board, Georgetown University
  66. 2003 - 2005
    Ad Hoc MemberData Audit Committee, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  67. 2003 - present
    Advisory Board MemberYoung Survival Coalition
  68. 2002 - 2012
    MemberChemotherapy Advisory Committee, Georgetown University Medical Center
  69. 2002 - 2012
    MemberData and Safety Monitoring Board, Georgetown University
  70. 2002 - 2008
    MemberClinical Competency Committee, Georgetown University Medical Center
  71. 2002 - 2006
    MemberData and Safety Monitoring Committee, Georgetown University
  72. 2002 - present
    Cadre MemberBreast Solid Tumor Correlative Sciences Working Group, Cancer and Leukemia Group B / Alliance for Clinical Trials in Oncology
  73. 2001 - 2002
    Committee Member /AuthorBreast Cancer Biomarker Concensus Panel (Metastatic), American Society of Clinical Oncology
  74. 2000 - 2012
    Faculty AdvisorMultidisciplinary Breast Cancer Conference, Georgetown University Medical Center
  75. 2000 - present
    MemberAmerican Association for Cancer Research
  76. 1999 - present
    MemberAmerican Society of Clinical Oncology
see more

Publications